INTELLIGENT BIO SOLUTIONS INC.

INBS

INTELLIGENT BIO SOLUTIONS INC.

INBS

Insider Sentiment (TTM):

Last Purchase:2023-10-04Last Sale:2022-02-17Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:208,155Shares Outstanding:1,594,496Institutional Ownership Pct.:13.05%

Earnings Market Reaction:

Filing Date:2026-08-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	4	7	1	2	1	3	2	4	6	9	1	0
Accounts Receivable Net Current	1	1	0	1	1	1	0	1	0	0	0	1
Receivable From Shareholders Or Affiliates For Iss…	-	-	9	-	-	-	-	-	-	-	-	-
Assets Current
Assets Current	7	10	12	4	4	5	4	6	9	12	3	3
Inventory Net	0	1	1	1	1	1	1	1	1	1	1	1
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	-	0	0	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	-	1	-	-	-	-	-	-	-	-	-	-
Other Assets Current	1	-	0	0	1	1	0	0	0	0	0	0
Property Plant And Equipment Net	0	0	0	0	0	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	2	2	2	2	0	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	3	3	3	3	4	4	4	4	4	5	5	5
Assets	12	15	18	10	8	10	9	12	14	17	9	9
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	4	4	4	4	5	1	1	2	2	2	2	4
Liabilities Current
Liabilities Current	5	5	5	5	5	5	4	6	5	6	5	7
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Income Current	-	-	-	-	-	2	2	3	2	2	2	2
Employee Related Liabilities Current	1	1	0	1	1	0	0	0	0	1	0	0
Notes Payable Current	-	-	0	0	0	0	0	0	1	0	0	0
Operating Lease Liability Noncurrent	2	1	2	1	-	0	0	0	0	0	0	0
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	0	0	0
Liabilities	7	6	7	7	5	5	4	6	6	6	6	7
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity
Stockholders Equity	6	9	11	4	3	5	4	6	8	11	3	1
Additional Paid In Capital	81	80	80	69	66	65	62	61	61	61	50	46
Retained Earnings Accumulated Deficit	-75	-71	-68	-66	-63	-59	-57	-55	-52	-49	-46	-44
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	-0	-0	-0	-1	-1	-0	-1	-1	-1	-1
Minority Interest	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	12	15	18	10	8	10	9	12	14	17	9	9
Common Stock Par Or Stated Value Per Share	0.01	0.01	-	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	100	100	-	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	3	2	1	1	1	1	0	0	0	0	0	0
Shares Outstanding	3	2	1	1	1	1	0	0	0	0	0	0
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-8.58%	-0.50%	9.58%	-17.24%	-43.88%	-50.82%	-38.60%	-43.86%	-60.53%	-	-	-
2025	-6.98%	-16.86%	-15.70%	2.11%	-43.04%	-42.62%	22.06%	30.88%	8.09%	5.44%	-20.41%	-33.54%
2024	47.58%	48.90%	-3.52%	-18.40%	-37.62%	-60.24%	-6.00%	-23.20%	-40.00%	-31.96%	-25.57%	-23.74%
2023	-	-	-	-	-	-	-	-	-	-13.81%	-84.48%	-68.07%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.44	2.11	2.37	0.89	0.77	1.12	0.92	1.14	1.57	2.02	0.57	0.39
Quick Ratio	1.35	1.80	2.26	0.76	0.65	0.97	0.76	1.01	1.42	1.87	0.39	0.25
Working Capital	2.17M	5.14M	7.05M	-577.71K	-1.21M	542.95K	-341.24K	800.11K	3.08M	5.81M	-2.24M	-4.15M
Leverage & Debt
Debt to Equity	1.26	0.70	0.62	1.93	1.93	0.94	1.07	0.97	0.68	0.55	1.80	6.04
Interest Coverage TTM	-106.88	-143.24	-132.55	-256.32	-174.62	-105.41	-80.83	-68.95	-61.52	-90.36	-196.86	-371.27
Debt Ratio	0.56	0.41	0.38	0.66	0.66	0.48	0.52	0.49	0.41	0.35	0.64	0.86
Efficiency & Turnover
Asset Turnover TTM	0.42	0.32	0.27	0.30	0.28	0.22	0.35	0.31	0.26	0.18	0.16	0.18
Days Sales Outstanding TTM	62.48	64.79	36.83	71.87	61.24	58.58	31.84	65.61	42.44	52.79	45.96	118.93
Receivables Turnover TTM	5.84	5.63	9.91	5.08	5.96	6.23	11.46	5.56	8.60	6.91	7.94	3.07
Per Share Metrics
Diluted EPS TTM	-8.47	-7.31	-11.92	-12.77	-20.11	-17.81	-23.64	-27.40	-63.98	-48.44	-141.44	-611.89
Free Cash Flow Per Share TTM	-8.20	-6.97	-10.01	-11.95	-18.37	-18.05	-22.29	-27.94	-60.09	-35.55	-78.61	-368.64
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	48.63%	47.25%	46.21%	43.08%	40.85%	58.81%	51.59%	48.31%	45.81%	26.22%	23.93%	32.10%
Operating Profit Margin TTM	-299.11%	-299.28%	-316.22%	-332.73%	-349.85%	-352.87%	-354.79%	-328.80%	-330.46%	-404.41%	-640.46%	-798.28%
Net Profit Margin TTM	-295.80%	-297.81%	-316.50%	-331.53%	-347.41%	-350.12%	-353.78%	-327.61%	-327.50%	-400.48%	-625.04%	-682.28%
Growth Metrics
Net Revenue Growth (1Y)	38.09%	33.26%	18.14%	3.26%	-1.90%	16.72%	41.06%	83.04%	147.58%	111.07%	131.74%	132.70%
Net Income Growth (1Y)	17.57%	13.35%	5.69%	4.50%	4.06%	2.05%	-20.16%	-12.11%	-4.44%	0.16%	165.95%	46.93%
EPS Growth (1Y)	-57.90%	-58.97%	-49.58%	-53.40%	-68.57%	-63.23%	-83.28%	-95.52%	-94.98%	-95.55%	-78.80%	-53.08%
Valuation Metrics
P/E TTM	-0.27	-0.46	-0.80	-0.80	-0.86	-0.81	-0.59	-0.63	-0.30	-0.87	-0.29	-0.20
P/B TTM	0.64	0.61	0.83	2.54	3.22	1.68	1.51	1.11	0.37	0.80	1.22	1.94
P/S TTM	0.80	1.36	2.53	2.65	2.97	2.83	2.09	2.07	0.98	3.49	1.79	1.38
Market Cap	3.38M	5.33M	9.06M	8.72M	9.07M	8.31M	6.35M	6.59M	3.06M	8.78M	3.85M	2.40M
Enterprise Value	-612.36K	-1.53M	8.33M	7.20M	8.25M	5.86M	4.51M	3.10M	-2.73M	-101.56K	3.33M	2.86M
Calculated Values
Free Cash Flow TTM	-12.08M	-11.11M	-9.52M	-10.22M	-9.69M	-10.42M	-10.11M	-10.65M	-9.57M	-7.39M	-7.47M	-7.16M
Net Debt	-3.99M	-6.86M	-727.37K	-1.52M	-822.76K	-2.45M	-1.84M	-3.49M	-5.79M	-8.88M	-517.50K	461.67K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-10-04Purchase

Owner: Towers, Christopher

Title: -

Shares: 9,090

Price/Share: -

Value: -

Shares Owned: 9,880

Relationship: Director

Ownership: Direct

2023-10-04Purchase

Owner: Sakiris, Spiro Kevin

Title: Chief Financial Officer

Shares: 112,727

Price/Share: -

Value: -

Shares Owned: 117,427

Relationship: Officer

Ownership: Indirect

2023-09-01Purchase

Owner: Simeonidis, Harry

Title: CEO

Shares: 50

Price/Share: $1.85

Value: $92.50

Shares Owned: 4,180

Relationship: Officer

Ownership: Direct

2022-06-22Purchase

Owner: Sakiris, Spiro Kevin

Title: Chief Financial Officer

Shares: 5,000

Price/Share: $0.65

Value: $3,250.00

Shares Owned: 50,228

Relationship: Officer

Ownership: Direct

2022-06-17Purchase

Owner: Sakiris, Spiro Kevin

Title: ChiefFinancial Officer

Shares: 15,970

Price/Share: $0.61

Value: $9,741.70

Shares Owned: 45,228

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-10-04	Towers, Christopher	Director	-	Direct	Purchase	9,090	-	-	9,880	4
2023-10-04	Sakiris, Spiro Kevin	Officer	Chief Financial Officer	Indirect	Purchase	112,727	-	-	117,427	4
2023-09-01	Simeonidis, Harry	Officer	CEO	Direct	Purchase	50	1.85	$92.50	4,180	4
2022-06-22	Sakiris, Spiro Kevin	Officer	Chief Financial Officer	Direct	Purchase	5,000	0.65	$3,250.00	50,228	4
2022-06-17	Sakiris, Spiro Kevin	Officer	ChiefFinancial Officer	Direct	Purchase	15,970	0.61	$9,741.70	45,228	4
2022-02-17	Life, Science Biosensor D…	Other	-	Direct	Sale	576,028	0.51	$293,774.28	1,081,804	4
2022-02-16	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.63	$63,000.00	1,657,832	4
2022-02-15	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.68	$68,000.00	1,757,832	4
2022-02-10	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.84	$84,000.00	2,057,832	4
2022-02-09	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.86	$86,000.00	2,157,832	4
2022-02-08	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.89	$89,000.00	2,257,832	4
2022-02-02	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.92	$92,000.00	2,357,832	4
2022-01-31	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.90	$90,000.00	2,457,832	4
2022-01-28	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	0.92	$92,000.00	2,557,832	4
2022-01-27	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	1.00	$100,000.00	2,657,832	4
2021-12-30	Parmakellis, Tom	Director	-	Direct	Purchase	4,500	1.55	$6,975.00	9,300	4
2021-12-17	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	200,000	1.49	$298,000.00	2,757,832	4
2021-12-16	Parmakellis, Tom	Director	-	Direct	Purchase	2,800	1.69	$4,732.00	4,800	4
2021-12-06	Sakiris, Spiro Kevin	Officer	ChiefFinancial Officer	Direct	Purchase	10,000	1.70	$17,000.00	29,258	4
2021-11-30	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	250,000	1.87	$467,500.00	2,957,832	4
2021-11-29	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	1.69	$169,000.00	3,207,832	4
2021-11-24	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	1.64	$164,000.00	3,307,832	4
2021-11-09	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	300,000	2.02	$606,000.00	3,407,832	4
2021-10-21	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	248,416	2.26	$561,420.16	3,707,832	4
2021-10-20	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	24,209	2.25	$54,470.25	3,956,248	4
2021-10-19	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	16,326	2.25	$36,733.50	3,980,457	4
2021-10-14	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,726	2.18	$219,582.68	3,996,783	4
2021-10-13	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	58,739	2.25	$132,162.75	4,097,509	4
2021-10-12	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	2.13	$213,000.00	4,156,248	4
2021-10-08	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	200,000	2.30	$460,000.00	4,256,248	4
2021-09-28	Parmakellis, Tom	Director	-	Direct	Purchase	1,000	2.40	$2,400.00	2,000	4
2021-09-28	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	200,000	2.48	$496,000.00	4,456,248	4
2021-09-24	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	200,000	2.66	$532,000.00	4,656,248	4
2021-09-23	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	2.77	$277,000.00	4,856,248	4
2021-09-22	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	2.80	$280,000.00	4,956,248	4
2021-09-21	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	2.83	$283,000.00	5,056,248	4
2021-09-20	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	100,000	2.90	$290,000.00	5,156,248	4
2021-09-17	Life, Science Biosensor D…	TenPercentOwner	-	Direct	Sale	45,152	3.29	$148,550.08	5,256,248	4
2021-06-21	Parmakellis, Tom	Director	-	Direct	Purchase	1,000	4.44	$4,440.00	1,000	4
2021-05-19	Sakiris, Spiro Kevin	Officer	Chief Financial Officer	Direct	Purchase	10,000	3.07	$30,700.00	16,258	4
2021-03-02	Gavrilenko, Victoria	Director	-	Direct	Purchase	37	8.09	$296.34	37	4
2021-02-24	Towers, Christopher	Director	-	Direct	Purchase	800	6.84	$5,472.00	800	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

13.05%

Inst. Shares: 208,155

Shares Outstanding: 1,594,496

2025-12-31

0.57%

Inst. Shares: 5,434

Shares Outstanding: 950,829

2025-09-30

158.12%

Inst. Shares: 1,351,411

Shares Outstanding: 854,693

2025-06-30

133.74%

Inst. Shares: 705,272

Shares Outstanding: 527,364

2025-03-31

151.97%

Inst. Shares: 877,163

Shares Outstanding: 577,191

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	208,155	1,594,496	13.05%
2025-12-31	5,434	950,829	0.57%
2025-09-30	1,351,411	854,693	158.12%
2025-06-30	705,272	527,364	133.74%
2025-03-31	877,163	577,191	151.97%
2024-12-31	76,823	453,582	16.94%
2024-09-30	252,418	381,109	66.23%
2024-06-30	315,542	159,275	198.11%
2024-03-31	585,017	207,986	281.28%
2023-12-31	300,398	94,966	-
2023-09-30	18,373	19,420	94.61%
2023-06-30	3,038	8,372	36.29%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

INTELLIGENT BIO SOLUTIONS INC. (INBS) — SEC Financial Statements & Analysis

INTELLIGENT BIO SOLUTIONS INC. (INBS) is a surgical & medical instruments & apparatus company, incorporated in DE. INTELLIGENT BIO SOLUTIONS INC. trades on Nasdaq as: INBS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INTELLIGENT BIO SOLUTIONS INC. reported a 38.09% year-over-year revenue growth, a Gross Profit Margin of 48.63% (TTM), a Debt-to-Equity ratio of 1.26x, a Price-to-Sales (P/S) ratio of 0.80x (TTM), a Price-to-Book (P/B) ratio of 0.64x (TTM), at a market cap of $3.38M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 38.09%
Gross Profit Margin TTM: 48.63%
Debt To Equity: 1.26x
P/S TTM: 0.80x
P/B TTM: 0.64x
Market Cap: $3.38M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is INTELLIGENT BIO SOLUTIONS INC. in?

INTELLIGENT BIO SOLUTIONS INC. (INBS) operates in the Surgical & Medical Instruments & Apparatus industry.

What is INBS's market cap?

INTELLIGENT BIO SOLUTIONS INC. (INBS) has a market capitalization of $3.38M as of 2026-06-30.

What exchange does INBS trade on?

INTELLIGENT BIO SOLUTIONS INC. (INBS) trades on the Nasdaq.

Where is INTELLIGENT BIO SOLUTIONS INC. incorporated?

INTELLIGENT BIO SOLUTIONS INC. is incorporated in DE.